김형석 로봇수술센터
진료분야 : 비뇨기 종양 (복강경 및 로봇 수술), 요로결석 (최소침습내시경수술), 전립선비대증 (홀렙수술 및 전립선 결찰술), 남성과학 (남성 불임, 정계정맥류, 발기부전), 배뇨장애 (과민성 방광 및 요실금), 요로감염
-
학력
- 서울대학교 의과대학
- 서울대학교 의과대학 대학원(비뇨의학)
-
경력
- 서울대학교 비뇨의학과 전임의
- 동국대학교 일산병원 비뇨의학과 조교수
- (현) 동국대학교 일산병원 비뇨의학과 부교수
- Department of Urology, Yale University College of Medicine, Visiting Professor
-
소속학회
- 대한비뇨의학회
- 대한비뇨기종양학회
- 대한비뇨내시경로봇학회
- 대한전립선학회
- 대한남성과학회
-
Choi J, Kim KH, Kim HS, Yoon HS, Kim JH, Kim JW, et al.
Comparative analysis of recurrence rates between intravesical gemcitabine and bacillus Calmette-Guérin induction therapy following transurethral resection of bladder tumors in patients with intermediate- and high-risk bladder cancer: A retrospective multicenter study
Investig Clin Urol, 2024 -
Kim HS, Lee HS, Ku JH
Prognostic impact of postoperative neutrophil-to-lymphocyte ratio on survival outcomes of patients treated with radical nephroureterectomy for upper urinary tract urothelial carcinoma: a single institution retrospective analysis using propensity score matching
J Cancer, 2023 -
Kim HS, Cho MC
Low Serum 25-Hydroxyvitamin D Level as a Potential Risk Factor of Erectile Dysfunction in Elderly Men with Moderate to Severe Lower Urinary Tract Symptoms
World J Mens Health, 2022 -
Kim HS, Seo HK
Emerging treatments for bacillus Calmette–Guérin-unresponsive non-muscle-invasive bladder cancer
Investig Clin Urol, 2021 -
Kim HS, Jang WS, Ham WS, Jung SI, Lee DH, Ku JH, et al.
Programmed Cell Death-Ligand 1 Expression Status in Urothelial Carcinoma According to Clinical and Pathological Factors: A Multi-Institutional Retrospective Study
Front Oncol, 2020 -
Seon DY, Kwak C, Kim HH, Ku JH, Kim HS
Prognostic implication of body mass index on survival outcomes in surgically treated nonmetastatic renal cell carcinoma: a single-institutional retrospective analysis of a large cohort
Ann Surg Oncol, 2020 -
Seon DY, Kwak C, Kim HH, Ku JH, Kim HS
Impact of perioperative blood transfusion on oncologic outcomes in patients with nonmetastatic renal cell carcinoma treated with curative nephrectomy: a retrospective analysis of a large, single-institutional cohort
Investig Clin Urol, 2020 -
Kim HS, Jeong CW, Kwak C, Kim HH, Ku JH
Novel nomograms to predict recurrence and progression in primary non-muscle-invasive bladder cancer: validation of predictive efficacy in comparison with European Organization of Research and Treatment of Cancer scoring system
World J Urol, 2019 -
Yoon HS, Kwak C, Kim HH, Kim HS, Ku JH
Second-Line Systemic Treatment for Metastatic Urothelial Carcinoma: A Network Meta-Analysis of Randomized Phase III Clinical Trials
Front Oncol, 2019 -
Kim HS, Kwak C, Kim HH, Ku JH
The Cancer of the Bladder Risk Assessment (COBRA) score for predicting cancer-specific survival after radical cystectomy for urothelial carcinoma of the bladder: External validation in a cohort of Korean patients
Urol Oncol, 2019 -
Kim HS, Yoo S, Cho YS
The Clinical Efficacy of Dual-Lumen Catheter Technique in Retrograde Intrarenal Surgery for the Management of Nephrolithiasis: A Propensity Score Analysis
J Endourol, 2018 -
Kim HS, Seo HK
Immune checkpoint inhibitors for urothelial carcinoma
Investig Clin Urol, 2018 -
Ahn C, Jeong CW, Kwak C, Kim HH, Kim HS, Ku JH
Ki-67 as a Prognostic Marker in Upper Urinary Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis
Clin Genitourin Cancer, 2018
-
Bladder Cancer: Research Advances and Clinical Challenges – Chapter 10. The Current Perspective on Systemic Immunotherapy Based on Immune Checkpoint Inhibition in Metastatic Urothelial Carcinoma
글
Nova Science Publishers, Inc., 2018 -
Bladder Cancer: Section I. Epidemiology, Etiology, and Pathophysiology. 2. Etiology (Risk Factors for bladder Cancer)
글
Elsevier, Inc., 2018 -
Oncologic Imaging: Urology – Chapter 3. Prostatic Tumors
글
Springer, Inc., 2017 -
Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges - Chapter 6. Histological Variants of Urothelial Carcinoma: Diagnostic, Prognostic and Therapeutic Implications
글
Nova Science Publishers, Inc., 2014
-
The optimal route of drug administration for BCG unresponsive NMIBC in non-cystectomy candidate: local (intravesical) or systemic (intravenous or oral). 제3회 UC summit
2021 -
Molecular landscape of NMIBC and subcellular risk factors for progression. BR VACCINE symposium
2021 -
The recent development of bladder sparing agents in BCG unresponsive NMIBC. The 19th KUOS MDC
2021 -
Clinical complete response after neoadjuvant chemotherapy for MIBC: what next?. 제2회 UC summit
2020 -
Beyond checkpoint inhibitors in the management of metastatic urothelial carcinoma. KPS-APSU joint international symposium
2020 -
Recent update in guidelines: urothelial carcinoma. KUCE
2020 -
PD-L1 expression in Korean bladder urothelial carcinoma. EAUOS
2019 -
Beyond BCG in non-muscle invasive bladder cancer. KPS-APSU joint international symposium
2019 -
Should we perform ureteroscopy before radical nephroureterectomy: advantages and limitations. 제1회 UC summit
2019 -
Current update of immunotherapy for metastatic bladder cancer. IRSL
2019
- http://news.bbsi.co.kr/news/articleView.html?idxno=3037070
- http://www.btn.co.kr/btntv/detail.asp?ls_StSbCode=CATPR_01&PID=P920&DPID=86248
- http://www.khealth.com/news/articleView.html?idxno=57486
- 대한비뇨기종양학회 방광암 연구회 간사
- 대한비뇨기종양학회 학술위원
- 대한남성과학회 홍보위원
- 대한전립선학회 학술위원
- 대한비뇨의학회 학술의원
- 2026-08-07 전립선 비대증이 의심될 때 어떤 검사를 할까?
- 2022-01-06 비뇨의학과 김형석 교수, 비타민 D와 발기부전 연관성 연구성과 발표
- 2021-07-06 비뇨의학과 김형석 교수, 소변으로 2번 이상 깨면 '야간뇨' ... 당뇨처럼 꾸준히 치료해야
- 2020-11-11 비뇨의학과 김형석 교수 논문 ‘프론티어즈 인 온콜로지’ 등재
- 2020-04-09 비뇨의학과 김형석 교수, 신장암 수술환자의 중요한 예후 예측인자 연구발표